Effect of Music Therapy on Infants With Neonatal Abstinence Syndrome

Description

This study examines the effects of 6 different music therapy interventions on outcomes for neonates diagnosed with Neonatal Abstinence Syndrome.

Conditions

NAS

Talk to us

Study Overview

On this page

Study Details

Study overview

This study examines the effects of 6 different music therapy interventions on outcomes for neonates diagnosed with Neonatal Abstinence Syndrome.

The Effect of Music Therapy on Neonates Diagnosed With Neonatal Abstinence Syndrome: A Pilot Study

Effect of Music Therapy on Infants With Neonatal Abstinence Syndrome

Condition
NAS
Intervention / Treatment

-

Contacts and Locations

New Orleans

Tulane University Hospital, New Orleans, Louisiana, United States, 70112

Hackensack

Joseph M. Sanzari Children's Hospital, Hackensack, New Jersey, United States, 07601

New Hyde Park

Northwell Health, New Hyde Park, New York, United States, 11040

New York

Mount Sinai West, New York, New York, United States, 10003

Valhalla

Maria Fareri Children's Hospital, Valhalla, New York, United States, 10595

Philadelphia

Drexel University/Hahnemann Hospital-College of Nursing and Health Professions, Philadelphia, Pennsylvania, United States, 19102

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Admitted to the NICU immediately postpartum
  • * Gestational age 28 weeks or older
  • * No identified hearing disorder
  • * Do not have a diagnosed developmental disability (i.e. Down Syndrome)
  • * Do not have Fetal Alcohol Syndrome
  • * Medically cleared to participate in the study by nurse or neonatologist
  • * Parent or legal guardian able/willing to give consent \& complete the PBQ (Postpartum Bonding Questionnaire)
  • * Admitted to the NICU at any time other than immediately postpartum
  • * Gestational age \<28 weeks old
  • * Has an identified hearing disorder
  • * Has diagnosed developmental disability (i.e. Down syndrome)
  • * Has Fetal Alcohol Syndrome
  • * Is not medically cleared to participate in the study by the nurse or neonatologist
  • * Parent or legal guardian unable/unwilling to give consent

Ages Eligible for Study

28 Weeks to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Icahn School of Medicine at Mount Sinai,

Joanne Loewy, PhD, PRINCIPAL_INVESTIGATOR, Icahn School of Medicine at Mount Sinai

Kathy Murphy, PhD, PRINCIPAL_INVESTIGATOR, Loyola University

Aimee Telsey, MD, STUDY_DIRECTOR, Icahn School of Medicine at Mount Sinai

Study Record Dates

2025-01